http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8063101-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a0327618c497c09893f3f321e05a0a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cffb44082220de55d755db0cc471fd4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_773f1212c89503aa4d44643c5b64fa70 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C403-24 |
| filingDate | 2008-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e095602c75a044140d1f2b7fafe09fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e65383b1430711d6870f888586d98d05 |
| publicationDate | 2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8063101-B2 |
| titleOfInvention | Carotenoid analogs and derivatives for the prevention of platelet aggregation |
| abstract | The presently described embodiments are directed to compositions that include one or more carotenoid analogs or derivatives for use in the treatment of a disorder associated with platelet aggregation. Certain embodiments provide for the use of said carotenoid analogs or derivatives in preparing compositions suitable for use in such treatments. Further embodiments provide for pharmaceutical compositions that include one or more carotenoid analogs or derivatives in combination with one or more additional compositions or medicaments suitable for the treatment of a disorder associated with platelet aggregation. Yet further embodiments provide for methods of treating a disorder associated with platelet aggregation that include administering to a subject who would benefit from such treatment pharmaceutical compositions suitable for inhibiting platelet aggregation in a subject undergoing said treatments, and that include carotenoid analogs or derivatives, optionally in combination with one or more additional antiplatelet agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400103-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688109-B1 |
| priorityDate | 2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1425.